Targeting Myeloid Cells in Combination Treatments for Glioma and Other TumorsAndy S. Ding, Michael Lim|Frontiers in Immunology|2019Cited by 52
EXTH-55. REPURPOSING THERAPEUTICS IN PATIENT-DERIVED GLIOMAS AND AN IDH1 MUTANT GLIOMA MODELChristin Schmidt, Anders I. Persson, Shirin IIkhanizadeh et al.|Neuro-Oncology|2017Cited by 0